Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 2
1976 1
1977 1
1980 3
1983 2
1985 3
1988 2
1990 3
1991 4
1992 3
1993 2
1994 1
1995 3
1996 2
1997 1
1998 6
1999 8
2000 5
2001 6
2002 4
2003 10
2004 12
2005 11
2006 15
2007 20
2008 14
2009 13
2010 8
2011 12
2012 8
2013 9
2014 9
2015 14
2016 4
2017 2
2018 4
2019 4
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

209 results
Results by year
Filters applied: . Clear all
Page 1
Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease.
Feagan BG, Sandborn WJ, Gasink C, Jacobstein D, Lang Y, Friedman JR, Blank MA, Johanns J, Gao LL, Miao Y, Adedokun OJ, Sands BE, Hanauer SB, Vermeire S, Targan S, Ghosh S, de Villiers WJ, Colombel JF, Tulassay Z, Seidler U, Salzberg BA, Desreumaux P, Lee SD, Loftus EV Jr, Dieleman LA, Katz S, Rutgeerts P; UNITI–IM-UNITI Study Group. Feagan BG, et al. N Engl J Med. 2016 Nov 17;375(20):1946-1960. doi: 10.1056/NEJMoa1602773. N Engl J Med. 2016. PMID: 27959607 Free article. Clinical Trial.
Vedolizumab as induction and maintenance therapy for Crohn's disease.
Sandborn WJ, Feagan BG, Rutgeerts P, Hanauer S, Colombel JF, Sands BE, Lukas M, Fedorak RN, Lee S, Bressler B, Fox I, Rosario M, Sankoh S, Xu J, Stephens K, Milch C, Parikh A; GEMINI 2 Study Group. Sandborn WJ, et al. N Engl J Med. 2013 Aug 22;369(8):711-21. doi: 10.1056/NEJMoa1215739. N Engl J Med. 2013. PMID: 23964933 Free article. Clinical Trial.
Addition of Granulocyte/Monocyte Apheresis to Oral Prednisone for Steroid-dependent Ulcerative Colitis: A Randomized Multicentre Clinical Trial.
Domènech E, Panés J, Hinojosa J, Annese V, Magro F, Sturniolo GC, Bossa F, Fernández F, González-Conde B, García-Sánchez V, Dignass A, Herrera JM, Cabriada JL, Guardiola J, Vecchi M, Portela F, Ginard D; ATTICA Study Group by the Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa [listed at the end of the article]. Domènech E, et al. Among authors: Sturniolo GC. J Crohns Colitis. 2018 May 25;12(6):687-694. doi: 10.1093/ecco-jcc/jjy023. J Crohns Colitis. 2018. PMID: 29490024 Clinical Trial.
Glucose transporter expression in the human colon.
Merigo F, Brandolese A, Facchin S, Missaggia S, Bernardi P, Boschi F, D'Incà R, Savarino EV, Sbarbati A, Sturniolo GC. Merigo F, et al. Among authors: Sturniolo GC. World J Gastroenterol. 2018 Feb 21;24(7):775-793. doi: 10.3748/wjg.v24.i7.775. World J Gastroenterol. 2018. PMID: 29467549 Free PMC article.
Ustekinumab induction and maintenance therapy in refractory Crohn's disease.
Sandborn WJ, Gasink C, Gao LL, Blank MA, Johanns J, Guzzo C, Sands BE, Hanauer SB, Targan S, Rutgeerts P, Ghosh S, de Villiers WJ, Panaccione R, Greenberg G, Schreiber S, Lichtiger S, Feagan BG; CERTIFI Study Group. Sandborn WJ, et al. N Engl J Med. 2012 Oct 18;367(16):1519-28. doi: 10.1056/NEJMoa1203572. N Engl J Med. 2012. PMID: 23075178 Free article. Clinical Trial.
Inflammatory Bowel Disease Therapies Adversely Affect Fertility in Men- A Systematic Review and Meta-analysis.
Banerjee A, Scarpa M, Pathak S, Burra P, Sturniolo GC, Russo FP, Murugesan R, D'Incá R. Banerjee A, et al. Among authors: Sturniolo GC. Endocr Metab Immune Disord Drug Targets. 2019;19(7):959-974. doi: 10.2174/1871530319666190313112110. Endocr Metab Immune Disord Drug Targets. 2019. PMID: 30864530
Toll-like receptor 2 regulates intestinal inflammation by controlling integrity of the enteric nervous system.
Brun P, Giron MC, Qesari M, Porzionato A, Caputi V, Zoppellaro C, Banzato S, Grillo AR, Spagnol L, De Caro R, Pizzuti D, Barbieri V, Rosato A, Sturniolo GC, Martines D, Zaninotto G, Palù G, Castagliuolo I. Brun P, et al. Among authors: Sturniolo GC. Gastroenterology. 2013 Dec;145(6):1323-33. doi: 10.1053/j.gastro.2013.08.047. Epub 2013 Aug 28. Gastroenterology. 2013. PMID: 23994200
Clinical Features and HLA Association of 5-Aminosalicylate (5-ASA)-induced Nephrotoxicity in Inflammatory Bowel Disease.
Heap GA, So K, Weedon M, Edney N, Bewshea C, Singh A, Annese V, Beckly J, Buurman D, Chaudhary R, Cole AT, Cooper SC, Creed T, Cummings F, de Boer NK, D'Inca R, D'Souza R, Daneshmend TK, Delaney M, Dhar A, Direkze N, Dunckley P, Gaya DR, Gearry R, Gore S, Halfvarson J, Hart A, Hawkey CJ, Hoentjen F, Iqbal T, Irving P, Lal S, Lawrance I, Lees CW, Lockett M, Mann S, Mansfield J, Mowat C, Mulgrew CJ, Muller F, Murray C, Oram R, Orchard T, Parkes M, Phillips R, Pollok R, Radford-Smith G, Sebastian S, Sen S, Shirazi T, Silverberg M, Solomon L, Sturniolo GC, Thomas M, Tremelling M, Tsianos EV, Watts D, Weaver S, Weersma RK, Wesley E, Holden A, Ahmad T. Heap GA, et al. Among authors: Sturniolo GC. J Crohns Colitis. 2016 Feb;10(2):149-58. doi: 10.1093/ecco-jcc/jjv219. Epub 2015 Nov 29. J Crohns Colitis. 2016. PMID: 26619893 Clinical Trial.
Diffusion-weighted magnetic resonance for assessing fibrosis in Crohn's disease.
Caruso A, Angriman I, Scarpa M, D'Incà R, Mescoli C, Rudatis M, Sturniolo GC, Schifano G, Lacognata C. Caruso A, et al. Among authors: Sturniolo GC. Abdom Radiol (NY). 2019 Aug 7. doi: 10.1007/s00261-019-02167-0. Online ahead of print. Abdom Radiol (NY). 2019. PMID: 31392397
A Phase 2a, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial of IBD98-M Delayed-Release Capsules to Induce Remission in Patients with Active and Mild to Moderate Ulcerative Colitis.
Fiorino G, Sturniolo GC, Bossa F, Cassinotti A, di Sabatino A, Giuffrida P, Danese S. Fiorino G, et al. Among authors: Sturniolo GC. Cells. 2019 May 30;8(6):523. doi: 10.3390/cells8060523. Cells. 2019. PMID: 31151306 Free PMC article. Clinical Trial.
209 results
Jump to page
Feedback